Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI-Reference-Cited by-同舟云学术

Novel imidazoline compounds as partial or full agonists of D2-like dopamine receptors inspired by I2-imidazoline binding sites ligand 2-BFI

Published:2010-10 Issue:19 Volume:18 Page:7085-7091
ISSN:0968-0896
Container-title:Bioorganic & Medicinal Chemistry
language:en
Short-container-title:Bioorganic & Medicinal Chemistry

Author:

Giorgioni Gianfabio,Ambrosini Dario,Vesprini Cristian,Hudson Alan,Nasuti Cinzia,Di Stefano Antonio,Sozio Piera,Ciampi Osele,Costa Barbara,Martini Claudia,Carrieri Antonio,Carbonara Giuseppe,Enzensperger Christoph,Pigini Maria

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference30 articles.

1. Novel insights in dopamine receptor physiology

2. Recent Progress in Development of Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

3. Antipsychotic drug action: antagonism, inverse agonism or partial agonism

4. Might Adrenergic α2C-Agonists/α2A-Antagonists Become Novel Therapeutic Tools for Pain Treatment with Morphine?

5. Imidazoline binding sites and their ligands: An overview of the different chemical structures

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 4RECENT PROGRESS IN THE SYNTHESIS OF IMIDAZOLE DERIVATIVES VIA CYCLIZATION OF ALKYNES AND NITROGEN COMPOUNDS;TARG HETEROCYCL SYST;2020

2. A Convenient Synthesis of Pyrazole‐imidazoline Derivatives by Microwave Irradiation;Journal of Heterocyclic Chemistry;2019-04-17

3. Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson’s Disease or Schizophrenia;ACS Chemical Neuroscience;2019-01-04

4. Synthesis and properties of seven- to nine-membered ring nitrogen heterocycles. Cyclic amidines and cyclic amidinium salts;Arkivoc;2018-05-27

5. Discovery of indolylpiperazinylpyrimidines with dual-target profiles at adenosine A2A and dopamine D2 receptors for Parkinson's disease treatment;PLOS ONE;2018-01-05